Is Australia behind on its rollout of the COVID-19 vaccine? Yes. Will it catch up? Most likely, yes. But there are perils in trying to go too fast, and in overpromising on deadlines.
Data from clinical trials and the real world COVID vaccine rollout suggest blood clots occur no more frequently in vaccinated people than they do in the general population.
The risk of COVID escaping from hotel quarantine or a health-care setting will never be zero. But in NSW and Queensland, was everything possible done to minimise the risk?
An out-of-control COVID epidemic in PNG would be a humanitarian and economic disaster for the nation itself, and a grave threat to the region.
The group has been at pains to stress it is not fundamentally about countering the 'Chinese threat'. But of course, that is primarily what it is about.
A virologist breaks down everything you need to know about the UK variant.
There is a difference between people who deliberately seek out vaccines outside the system, and those who are offered them because they're about to expire.
From Queen Elizabeth to Willie Nelson, celebrities have long used their platforms to promote public health information. Why do people trust celebrities for health advice more than the government?
With four COVID-19 vaccines approved for use in Canada, it's time to answer FAQs about efficacy, immunity, eradication and variants.
One important metric by which we can measure the success of our public health system: Ensuring everyone has access to immunization in their community.
As New Zealand prepares to roll out COVID-19 vaccines to the general population, health authorities will need to reach those who remain hesitant through information sources they trust.
Even if you're vaccinated, you still need to come forward for COVID testing, even if you have the mildest symptoms.
Religious opposition over a link to abortions performed decades ago and misunderstandings about effectiveness could lead to a nightmare of angry patients and wasted vaccine.
Immunity fades rapidly for some infections (influenza) but lasts a lifetime with others (measles). Here's what we know about COVID.
Italy's decision to block export of AstraZeneca vaccines to Australia will likely not impact our vaccine roll-out. But vaccine scarcity is a looming problem in other parts of the world.
The FDA has indicated booster shots, to cover coronavirus variants, won't need to go through lengthy phase 3 clinical trials. Instead, they can be tested in smaller trials, which will save time.
South Africa's constitutional values of good public governance and transparency in public procurement have been sacrificed in the process of buying COVID-19 vaccines.
Real-world studies of vaccines aren't directly comparable with clinical trials, but their results are still good news.
South Africa is aiming for 67% coverage, which translates to about 40 million people by the end of 2021.
Most of us don't know yet when or where we'll receive our COVID vaccination. But particularly as there's a risk of scams, it's important to be clear on how this process will (and won't) play out.